Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
VN1R34P, or vomeronasal 1 receptor 34 pseudogene, is annotated as a human pseudogene located on chromosome 7. It belongs to the vomeronasal 1 receptor gene family, which encodes G protein-coupled receptors involved in pheromone detection in the vomeronasal organ of many vertebrates. In humans, however, VN1R34P is classified as a pseudogene, meaning it is an inactive, non-functional remnant of a gene that has lost its ability to encode a functional protein. There is no evidence supporting a biological function, disease relevance, or pharmacological targeting of this pseudogene in humans. It is not considered a therapeutic drug target, nor is it associated with specific biomarkers, safety concerns, or known drug interactions. VN1R34P does not produce a functional receptor protein in humans and lacks therapeutic or diagnostic relevance. Its classification as a pseudogene reflects its evolutionary origin from a functional vomeronasal receptor gene, with no known implications for human health or disease.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vomeronasal 1 receptor 34 pseudogene (VN1R34P).